| Placebo | Steroid | p Value | |
| Age (years)* | 44.1 (17.0) | 49.9 (13.0) | 0.22‡ |
| Sex† | |||
| Male | 11 (50.0) | 11 (55.0) | 0.75§ |
| Female | 11 (50.0) | 9 (45.0) | |
| Organisms† | |||
| Coagulase-negative Staphylococcus | 3 (13.64) | 2 (9.52) | 0.51§ |
| Diphtheroids | – | 1 (4.76) | |
| Staphylococcus aureus | 2 (9.09) | – | |
| Streptococcus pneumoniae | 10 (45.45) | 9 (42.86) | |
| Viridans-group Streptococcus spp. | 1 (4.55) | 3 (14.29) | |
| Haemophilus influenzae | – | 1 (4.76) | |
| Moraxella spp. | 1 (4.55) | – | |
| Pseudomonas spp. (non-aeruginosa) | – | 1 (4.76) | |
| Pseudomonas aeruginosa | 4 (18.18) | 4 (19.05) | |
| Aeromonas hydrophila | 1 (4.55) | – | |
| Enrolment visual acuity (logMAR)* | 1.15 (0.63) | 1.28 (0.54) | 0.50‡ |
| Enrolment infiltrate/scar diameter (mm)* | 1.8 (1.6) | 2.0 (1.2) | 0.63‡ |
*Values are mean (SD).
†Values are n (%).
‡Independent sample t test.
§Fisher’s exact test.